|
|
Line 103: |
Line 103: |
| ==Autism== | | ==Autism== |
|
| |
|
| ===[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394231/ An Exploratory Trial of Transdermal Nicotine for Aggression and Irritability in Adults with Autism Spectrum Disorder]=== | | ===2018 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394231/ An Exploratory Trial of Transdermal Nicotine for Aggression and Irritability in Adults with Autism Spectrum Disorder]=== |
| *Taken together, our study provides evidence for the feasibility and tolerability of [[Abbreviations|'''transdermal nicotine (TN/TNP)''']] in a small sample of adults with severe [[Abbreviations|'''Autism Spectrum Disorder (ASD)''']] symptoms and pathological chronic aggression and irritability. | | *Taken together, our study provides evidence for the feasibility and tolerability of [[Abbreviations|'''transdermal nicotine (TN/TNP)''']] in a small sample of adults with severe [[Abbreviations|'''Autism Spectrum Disorder (ASD)''']] symptoms and pathological chronic aggression and irritability. |
| *Our results also suggest that TN may have a beneficial effect on aggression, irritability, and sleep in ASD, though the sample size of this study is too small to make definitive conclusions. | | *Our results also suggest that TN may have a beneficial effect on aggression, irritability, and sleep in ASD, though the sample size of this study is too small to make definitive conclusions. |